What Went Wrong with the IMMUNI Contact-Tracing App in Italy? A Cross-Sectional Survey on the Attitudes and Experiences among Healthcare University Students.
COVID-19
IMMUNI app
digital contact tracing
students
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
10 Jun 2022
10 Jun 2022
Historique:
received:
16
05
2022
revised:
07
06
2022
accepted:
09
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
The adoption of digital contact-tracing apps to limit the spread of SARS-CoV-2 has been sup-optimal, but studies that clearly identify factors associated with the app uptake are still limited. In April 2021, we administered a questionnaire to healthcare university students to investigate their attitudes towards and experiences of the IMMUNI app. A multivariable logistic regression model was built to identify app download predictors. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were calculated. We surveyed 247 students. Most respondents (65.6%) had not downloaded IMMUNI, reporting as the main reason the perceived app uselessness (32.7%). In the multivariable analysis, being advised to use the app (aOR: 3.21, 95%CI: 1.80-5.73), greater fear of infecting others (aOR: 1.50, 95%CI: 1.01-2.23), and greater trust in the institutional response to the emergency (aOR: 1.33, 95%CI: 1.00-1.76) were positively associated with the outcome, whereas greater belief in the "lab-leak theory" of COVID-19 was a negative predictor (aOR: 0.75, 95%CI: 0.60-0.93). Major technical issues were reported by app users. Targeted strategies aimed at improving awareness of digital health applications should be devised. Furthermore, institutions should invest in the development of these technologies, to minimize technical issues and make them accessible to the entire population.
Identifiants
pubmed: 35743902
pii: life12060871
doi: 10.3390/life12060871
pmc: PMC9225335
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Public Health. 2022 Mar;7(3):e259-e273
pubmed: 35180434
JMIR Public Health Surveill. 2021 Jan 6;7(1):e25701
pubmed: 33326411
PLoS One. 2021 Mar 17;16(3):e0248627
pubmed: 33730091
Vaccines (Basel). 2021 Nov 07;9(11):
pubmed: 34835223
JAMA. 2020 Jun 2;323(21):2129-2130
pubmed: 32324202
Front Digit Health. 2021 Jun 17;3:660823
pubmed: 34713135
J Med Internet Res. 2021 Feb 9;23(2):e23467
pubmed: 33493125
JMIR Mhealth Uhealth. 2021 Nov 22;9(11):e29181
pubmed: 34698645
Engineering (Beijing). 2020 Oct;6(10):1064-1066
pubmed: 32953197
Health Inf Sci Syst. 2021 Apr 13;9(1):18
pubmed: 33868671
JMIR Public Health Surveill. 2020 Sep 1;6(3):e20572
pubmed: 32755882
Front Public Health. 2021 Aug 20;9:721952
pubmed: 34490198
Acta Biomed. 2021 Dec 10;92(S6):e2021439
pubmed: 34889315
JMIR Public Health Surveill. 2020 Dec 23;6(4):e24598
pubmed: 33302255
J Med Internet Res. 2021 Oct 7;23(10):e27301
pubmed: 34313588
J Med Internet Res. 2021 Mar 3;23(3):e26399
pubmed: 33566793
J Gen Intern Med. 2021 Mar;36(3):753-761
pubmed: 33403622
Nat Hum Behav. 2021 Feb;5(2):247-255
pubmed: 33479505
Ethics Inf Technol. 2021;23(3):285-294
pubmed: 33106749
Soc Sci Humanit Open. 2021;4(1):100212
pubmed: 34642660
PLoS One. 2021 Nov 1;16(11):e0258945
pubmed: 34723981
Cochrane Database Syst Rev. 2020 Aug 18;8:CD013699
pubmed: 33502000
J Med Internet Res. 2021 Mar 2;23(3):e23362
pubmed: 33577466
JMIR Mhealth Uhealth. 2020 Aug 28;8(8):e19857
pubmed: 32759102
Healthcare (Basel). 2021 Dec 30;10(1):
pubmed: 35052231
Ann Ist Super Sanita. 2017 Jul-Sep;53(3):205-212
pubmed: 28956799
PLoS One. 2020 Oct 29;15(10):e0241473
pubmed: 33120402
Prev Med. 2022 Feb;155:106927
pubmed: 34954244
JMIR Mhealth Uhealth. 2021 Jun 7;9(6):e27753
pubmed: 34003764
N Engl J Med. 2021 Aug 5;385(6):484-487
pubmed: 34010529